Pharmarise Holdings: Confirmatory letter.
Pharmarise Holdings: Financial Report - 38th Term (2023/06/01 - 2024/05/31)
Pharmarise Holdings: Extraordinary Report
Pharmarise Holdings: Announcement regarding the dividends of surplus funds.
Pharmarise Holdings Faces Profit Decline, Eyes Recovery
Buy demand next week for Maesawa Chemical Industry and others.
[Buy demand for next week (table)] Code; Stock; Stock price impact; Buy demand; Credit multiplier; Closing price; Previous day comparison <9046>: Kobe Electric Railway; 390%; 35,900; 0.06; 2772; -3 <2796>: Farmalize; 345%; 7,600; 7.09; 635; -2 <3198>: SFP; 315%; 77,900; 0.15; 2163; -5 <8118>: King; 254%; 6,100; 62.03; 755; 0 <9428>: Crops; 20
Pharmarise Holdings To Go Ex-Dividend On May 29th, 2025 With 14 JPY Dividend Per Share
July 2nd (Japan Standard Time) - $Pharmarise Holdings(2796.JP)$ is trading ex-dividend on May 29th, 2025.Shareholders of record on May 31st, 2025 will receive 14 JPY dividend per share. The ex-dividen
Takashimaya revises upwards on February 25, operating profit of 55 billion yen (previously 50 billion yen).
Takashimaya <8233> announced a revision of its financial estimates for the fiscal year ending in February 2025. The operating revenue was revised upward from ¥497 billion to ¥511.4 billion, while the operating profit was revised upward from ¥50 billion to ¥55 billion, reflecting the strong performance of inbound sales in domestic department stores. The first quarter financial results for the February 2025 period showed an operating revenue of ¥120.125 billion, up 13.8% YoY, and an operating profit of ¥17.295 billion, up 56.7% YoY. [Positive rating] Intellix<8940> Revision | <
Pharmarise Holdings: Announcement of differences between financial estimates and actual results for the entire fiscal year of May Heisei 6
Pharmarise Holdings: FY May 2024 financial results announcement (Japan GAAP) (Consolidated)
Pharmarise FY Loss Y351.00M Vs Net Y333.00M
J front, Claudia, Sanyosho, Takashimaya (28 days)
※The above calendar is only a plan and may be subject to change due to the company's convenience. ---------------------------------------June 28th (Fri) <2164> Regional Newspaper Company <2186> Soveral <2685> Adastria <2778> Palermo HD <2796> Farmalize <2935> Pickles HD <3050> DCM <3086> J Front
YE Digital, Harrows, Okuwa, Heiwa-do (27th)
※The above calendar is subject to change due to company circumstances. --------------------------------------- June 27th (Thu) <2354> YE Digital <2742> Halos <3075> Choshi Maru <7068> F-Force G <7447> Nagai Rebe <8217> Okuwa <8276> Heiwado ----------------------
Rui Guang, Opto-Electronics, Asuka, Seki Chu (26th day)
※The above calendar is only a plan and may be subject to change due to corporate reasons. ---------------------------------------June 26 (Wed) <6279> Mizuho Light <6664> Opto-Electronic <7227> Asuka <9976> Sekichu ---------------------------------------June 27 (Thu) <2354> YE
Denko-sha, NaITO, Sugi HD (25th).
※The above calendar is tentative and subject to change due to company circumstances. --------------------------------------- June 25th (Tue) <6365> Denkyosha <7624> NaITO <7649> Sugi HD --------------------------------------- June 26th (Wed) <6279> Mizuho <6664> Opto Electronics
Asahi, Ichibanya Shimamura (24th)
※The above calendar is only tentative and subject to change due to company's convenience. --------------------------------------- June 24 (Mon) <3333>Asahi <7630>Ichibanya <8227>Shimamura --------------------------------------- June 25 (Tue) <6365>Dengyo-sha <7624>NaITO <7
Mitsui High-tech's operating profit for the first quarter increased by 3.9% to 3.971 billion yen, with a stock split of 1:5.
Mitsui High-tec <6966>'s Q1 fiscal year ending January 2025 revenue was JPY 50.431 billion, a YoY increase of 11.4%, and operating profit was JPY 3.971 billion, a YoY increase of 3.9%. The fiscal year ending January 2025 plan is JPY 237.0 billion in revenue, a 21% increase compared to the previous year, and JPY 21.0 billion in operating profit, a 15.9% increase compared to the previous year. It also announced a stock split of 1 share into 5 shares effective August 1. [Positive Evaluation] <184A> Learning Aid
Pharmarise Holdings: Announcements of individual stocks regarding the revision of the forecasted financial estimates for the full fiscal year ending May 2024 and recording of special losses.
Pharmarise Holdings' Attributable Profit Down 15% in Fiscal Nine Months on Higher Expenses Following M&A
Pharmarise's Fiscal H1 Attributable Profit Soars as Net Sales Rise
No Data
No Data